Acting upon the Food and Drug Administration’s (FDA) request, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) decided unanimously on Thursday to recommend …
VRBPAC recommends harmonizing COVID vaccines content Read More »
Ahead of the U.S. Food and Drug Administration’s (FDA) meeting to discuss the nation’s COVID-19 vaccine strategy, two studies published Wednesday provide more evidence of …
Bivalent boosters halve infection, hospitalization risk of XBB variants, studies show Read More »
Australian scientists are a step closer to finding new and more effective treatments for lymphoma and lung cancer after opening up new treatment options that …
Australian scientists work on helping the immune system kill cancer cells Read More »
Over the last 10 years, partnering has been an essential driver of the U.S. biotech business, with external partnerships increasing by 152% and tripling in …
Partnering is a big deal at the BIO CEO & Investor Conference in NYC, Feb. 6-7 Read More »
!["[...] Price controls reduce access to treatments and cures.” — The Wall Street Journal Editorial Board](https://www.bio.news/wp-content/uploads/2023/01/Antibiotics-1.jpg)
In light of the drastic rebate hike prompted by inflation and COVID-driven increases in demand, the U.K. is no longer a viable market for pharmaceutical …
European lessons on drug price controls teach the U.S. how ‘not to do it’ Read More »
To simplify and streamline the COVID-19 vaccination process while pushing for increased vaccination rates, the U.S. Food and Drug Administration (FDA) proposed updating the COVID-19 …
Rachel King, Interim CEO of the Biotechnology Innovation Organization (BIO), described the organization’s work and goals for 2023 at the Maryland Tech Council (MTC)’s annual …
BIO’s Interim CEO discusses biotech policy, optimism with industry in Maryland Read More »
The U.S. Patent and Trademark Office (USPTO) and the U.S. Food and Drug Administration (FDA) convened a joint session on drug patent systems yesterday. This …
When the largest private insurance companies use their leverage to save on the cost of prescription drugs, they make it harder for patients to obtain …
Excluding drugs from coverage helps PBMs keep profits higher Read More »
Moderna is edging closer to launching a new investigational mRNA vaccine to fight the respiratory syncytial virus (RSV), which was 83.7% effective at preventing infection …
Moderna RSV vaccine is 83.7% effective in Phase 3 trial Read More »
A new partnership will use biotechnology to bring baby formula closer to mothers’ milk, Good Day BIO reports. Ginkgo Bioworks announced yesterday it’s partnering with …
Ginkgo Bioworks will use biotech to boost baby formula’s gut-health properties Read More »
